Synopsis

Ocular Therapeutics have undergone tremendous advances both for anterior and posterior segment diseases in the last one decade. A wide array of new safe, effective drugs with least side effects are available for various ophthalmic surgeries and ocular diseases— new effective FOTE drug therapy based on advanced technology along with invasive and noninvasive ocular drug delivery systems are now available which include the use of nanoparticles, liposomes and dendrimers. Versidoser drug delivery platforms shall revolutionize the FOTE drug delivery system. Genetic, regenerative drugs and stem cell based drug therapy shall make the treatment customized to individual need of ocular disease extent making it more cost-effective and safe.  The third edition of this book has been completely updated with addition of all new ocular drugs and delivery systems in every group of medicine used in ophthalmic disease and surgeries. Sixty-nine chapters of this line have been grouped as preliminary section, Applied Ocular Therapeutics and Recent Advances. In this comprehensive book leading International Ocular Drug Experts have shared their experiences and evidence-based knowledge in the form of chapters.